TG Therapeutics is off to the races after updating phase 2 results for one of its leading compounds. Find out what the buzz is all about, and whether you should be buying into it.
TG Therapeutics is off to the races after updating phase 2 results for one of its leading compounds. Find out what the buzz is all about, and whether you should be buying into it.